Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Numinus Wellness Inc NUMIF


Primary Symbol: T.NUMI

Numinus Wellness Inc. is a mental health care company. The Company focuses on advancing traditional and behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies. Its segments include Clinical research operations, Practitioner Training, Clinic network, and Corporate. Clinical research operations segment is focused on licensed psychedelic research and provides clinical research management services to academic institutions and biotechnology companies. Practitioner Training segment is engaged in education and training for research and drug development organizations to support clinical trials and commercialization efforts. Clinic network segment includes wellness clinics, which is engaged in providing clinical services from psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management. Corporate segment includes finance, marketing, information technology, legal, and human resources.


TSX:NUMI - Post by User

Post by Traderstock101on Jul 11, 2024 9:51am
109 Views
Post# 36128085

Numinus to release Q3 results, host call July 11

Numinus to release Q3 results, host call July 11

News Release

Mr. Craig MacPhail reports

NUMINUS TO HOST Q3 FISCAL 2024 RESULTS CONFERENCE CALL ON JULY 11, 2024

Numinus Wellness Inc. will release its financial results for the quarter ended May 31, 2024, after market close on Thursday, July 11, 2024.

Interested parties are invited to participate in the company's third quarter 2024 results conference call and webcast, which will be held on the same day at 5:30 p.m. Eastern Time/2:30 p.m. Pacific Time. During the call, Numinus executives will review the company's performance and recent initiatives.

A question-and-answer session will follow management's prepared remarks. At this time, the operator will provide instructions for qualified equity analysts to submit questions. Investors are invited to submit questions by e-mail to invest@numinus.com. A selection of questions will be answered by management on the call, and all e-mailed questions will be responded to by e-mail.

To listen to the live webcast, please register.

The webcast will also be archived on the events and presentations page of Numinus's investor relations website.

To participate in the live conference call, please use the following dial-in information:

 

  • 1-888-330-3632 (toll-free North America);
  • 1-646-960-0837 (international);
  • Ask to participate in Numinus's Q3 2024 results call.

 

To avoid any delays in joining the call, please dial in at least five minutes before the call starts. If prompted, please provide conference passcode 3547386.

About Numinus Wellness Inc.

Numinus helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model -- including psychedelic research and clinic care -- is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, it is leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.

<< Previous
Bullboard Posts
Next >>